speb/financial-data huggingface dataset:
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 7727660000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 26720330000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 7727660000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 36130750000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 10492880000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 27084270000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 7856040000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -1850000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -670000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Net Interest Income: -1702930000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -746410000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Net Investment Properties Purchase And Sale: -92940000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Net Investment Properties Purchase And Sale: -37840000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -14342110000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -10338330000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 124490000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -198680000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 2240000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 5080000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1702930000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -746410000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Net PPE: 51037340000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 51037340000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -14704550000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -3867950000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 122250000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -203760000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 120044790000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 120044790000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 1505640000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 1505640000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 116020000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 116020000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 524060000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 524060000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 491420000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 491420000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 40686810000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 12217240000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Normalized Income: 25778944394.90
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 7727660000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 38106670000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 15982000000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Operating Income: 37157340000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Operating Income: 10635110000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Operating Revenue: 282695080000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 88644770000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 150550508.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 150550508.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 316390000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 316390000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 50610000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 50610000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 959660000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 959660000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 40970000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 40970000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 312810000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 312810000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 1151490000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 396050000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: -10000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: -10000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 1505640000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1505640000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 300760000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 604180000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 8704470000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 5373430000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Payable: 1014110000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 1014110000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Properties: 2502410000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 2502410000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 2125820000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 2125820000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 36719530000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 36719530000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Other Special Charges: 69890000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Payables: 22849210000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Payables: 22849210000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 52220000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 52220000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 6073470000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 6073470000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Pretax Income: 36130750000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 10492880000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 922510000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 487050000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -1850000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -670000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -160345110000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -52269630000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment Properties: -92940000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Purchase Of Investment Properties: -37840000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -14803290000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -3871740000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 24944670000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 24944670000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 221601730000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 67867490000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 3858690000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 977950000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 114660000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 114660000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -100600000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -29740000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 3705330000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 3705330000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 107981180000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 107981180000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 146003000000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 41931300000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 98740000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 3790000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 6542240000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1859770000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 8596670000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1859770000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Share Issued: 150550508.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 150550508.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 122250000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: -203760000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Special Income Charges: -71050000.00
POLYCAB.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 304870000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 62140000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 120085760000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 120085760000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 120044790000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 120044790000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 314434394.90
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Tax Provision: 9046480000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 2636840000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.25
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
POLYCAB.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -8829630000.00
POLYCAB.NS cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -2031100000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Total Assets: 204761900000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 204761900000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 120478430000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 120478430000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Total Debt: 45011360000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 45011360000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 121267690000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 121267690000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Total Expenses: 245537740000.00
POLYCAB.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 78009660000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 83494210000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 83494210000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 58156840000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 58156840000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3841770000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 3841770000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 477170000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 3843250000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 3843250000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 1255820000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1255820000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 0.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 0.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Work In Process: 6083520000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 6083520000.00
POLYCAB.NS balance_sheet (annual, 2026-03-31) — Working Capital: 66952620000.00
POLYCAB.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 66952620000.00
POLYCAB.NS income_statement (annual, 2026-03-31) — Write Off: 1160000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — +Operating Expense: 9243950000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — +Total Revenue: 82097320000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 150573431.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Basic EPS: 52.09
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 62520080000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 1028700000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 1028700000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 151008279.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Diluted EPS: 51.94
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 7843370000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — EBIT: 11382440000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — EBITDA: 12411140000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Gross Profit: 19577240000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Interest Expense: 800210000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 800210000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Minority Interests: -123170000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Net Income: 7843370000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 7843370000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 7966540000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 7843370000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 7843370000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 7966540000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Net Interest Income: -800210000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -800210000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 12411140000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Normalized Income: 7843370000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Operating Income: 10333290000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Operating Revenue: 82097320000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: 1049150000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 4238290000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Otherunder Preferred Stock Dividend: 0.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Pretax Income: 10582230000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 62520080000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 1028700000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Selling And Marketing Expense: 1362210000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Selling General And Administration: 1362210000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 0.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Tax Provision: 2615690000.00
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.25
POLYCAB.NS income_statement (quarterly, 2026-06-30) — Total Expenses: 71764030000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3182435000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 3912701000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -3790000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Amortization: 26784000.00
POLYMED.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 26784000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 95888694.00
POLYMED.NS income_statement (annual, 2022-03-31) — Basic EPS: 15.28
POLYMED.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 985570000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 0.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 77574000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 0.00
POLYMED.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 95964194.00
POLYMED.NS income_statement (annual, 2022-03-31) — Diluted EPS: 15.27
POLYMED.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 3627000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 326638000.00
POLYMED.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 171630000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 2070079000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Interest Income: 22913000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 22913000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Investment Properties: 38688000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 97688000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 763315000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 5820369000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 0.00
POLYMED.NS income_statement (annual, 2022-03-31) — Minority Interests: 0.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 39822000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 329256000.00
POLYMED.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 110508000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Other Payable: 158396000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Other Special Charges: -5305000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 202486000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 156196000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 990338000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 22357000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 22357000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 3627000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 3990412000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 150766000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 322396000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 90103000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 24397000.00
POLYMED.NS balance_sheet (annual, 2022-03-31) — Work In Process: 256159000.00
POLYMED.NS income_statement (annual, 2022-03-31) — Write Off: 6606000.00
POLYMED.NS income_statement (annual, 2023-03-31) — +Operating Expense: 3814867000.00
POLYMED.NS income_statement (annual, 2023-03-31) — +Total Revenue: 11086582000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 923148000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 2354320000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -3663945000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 3924045000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -18785000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Amortization: 29194000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 29194000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 67386000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 95916495.00
POLYMED.NS income_statement (annual, 2023-03-31) — Basic EPS: 18.69
POLYMED.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 77574000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1672729000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -2392748000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 25829000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 479723000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 70624000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 3012875000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -239730000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 70624000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -402905000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -11261000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 157044000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Change In Payable: 37692000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -287968000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -494597000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -6949000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Common Stock: 479723000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 12416272000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 3513000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 1095902000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 5093215000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Current Assets: 8066877000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 12336000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1289327000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1301663000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 8376000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 2933026000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 5520000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Depreciation: 542474000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 571668000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 571668000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 542474000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 96020945.00
POLYMED.NS income_statement (annual, 2023-03-31) — Diluted EPS: 18.67
POLYMED.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 1792825000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 3692000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 5386000.00
POLYMED.NS income_statement (annual, 2023-03-31) — EBIT: 2460345000.00
POLYMED.NS income_statement (annual, 2023-03-31) — EBITDA: 3032013000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — End Cash Position: 70624000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -125053000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 512826000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -482228000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 40069000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -1003000.00
POLYMED.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 175733000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Goodwill: 285811000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 501298000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 2373105000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 10657793000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Gross Profit: 5993367000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Interest Expense: 85431000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 85431000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Interest Income: 59740000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 59740000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -84575000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 15831000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Inventory: 2086548000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 13880611000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1792416000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 9089000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 67386000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 76420000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 3513000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 994350000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 13493000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 175012000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 188505000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 76420000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 46023000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 6870074000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Minority Interests: 0.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 3513000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Net Debt: 1393715000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 17545000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Net Income: 1792825000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 1792825000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 1792825000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 1792825000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 1792825000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 2374914000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 1792825000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Net Interest Income: -48834000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 577638000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 209899000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 209899000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -48834000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Net PPE: 6993848000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -2391271000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 11914974000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 27352000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 154347000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 46023000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 51635000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 3072501000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Normalized Income: 1823308415.20
POLYMED.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1910520000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Operating Income: 2178500000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Operating Revenue: 11086582000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 95944342.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 261968000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 3000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 23053000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 215487000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 80792000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -26773000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -2000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 1000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 32976000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 721760000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Payable: 218441000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Properties: 24738000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 72621000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 2942251000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Other Special Charges: -1003000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Payables: 1145281000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 19274000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 256854000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 192865000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Pretax Income: 2374914000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 5939000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -2392748000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1157289000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 5093215000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 571668000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 19296000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 19296000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Research And Development: 178025000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 3692000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 5277486000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 1477000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 205118000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 380851000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Share Issued: 95944342.00
POLYMED.NS income_statement (annual, 2023-03-31) — Special Income Charges: -419000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 12416272000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 11914974000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -10004584.80
POLYMED.NS income_statement (annual, 2023-03-31) — Tax Provision: 582089000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.25
POLYMED.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 81988000.00
POLYMED.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -578669000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Total Assets: 15772092000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 12591284000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Total Debt: 1490168000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 12416272000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Total Expenses: 8908082000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3355820000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 7705215000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 422794000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 23143000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 8376000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -40488000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -40488000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Work In Process: 335641000.00
POLYMED.NS balance_sheet (annual, 2023-03-31) — Working Capital: 5133851000.00
POLYMED.NS income_statement (annual, 2023-03-31) — Write Off: 1422000.00
POLYMED.NS income_statement (annual, 2024-03-31) — +Operating Expense: 4587229000.00
POLYMED.NS income_statement (annual, 2024-03-31) — +Total Revenue: 13656937000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 955976000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2699388000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -4213366000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 3933251000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -29917000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Amortization: 34911000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 34911000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 275368000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 95946790.00
POLYMED.NS income_statement (annual, 2024-03-31) — Basic EPS: 26.92
POLYMED.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 70624000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 2406954000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -2770159000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 39377000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 479858000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 120531000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 2859868000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -287400000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 120531000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -123756000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -47241000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 91273000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Change In Payable: 37615000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -366856000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -406570000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 49907000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Common Stock: 479858000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 14700535000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 2638000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 987497000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 6043163000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Current Assets: 8416034000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 18507000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1691265000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1709772000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 35597000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 3512144000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 5719000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Depreciation: 604354000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 639265000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 634443000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 599532000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 96020790.00
POLYMED.NS income_statement (annual, 2024-03-31) — Diluted EPS: 26.90
POLYMED.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 2582597000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 4125000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 5426000.00
POLYMED.NS income_statement (annual, 2024-03-31) — EBIT: 3549665000.00
POLYMED.NS income_statement (annual, 2024-03-31) — EBITDA: 4188930000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — End Cash Position: 120531000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -201535000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 280555000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -109337000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -209488000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -6228000.00
POLYMED.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 209592000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Goodwill: 285811000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 535756000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2729305000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 13423252000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Gross Profit: 7613774000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Interest Expense: 106974000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 106974000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Interest Income: 118356000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 118356000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -110240000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 131770000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Inventory: 2210304000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 16400205000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -2409380000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 5837000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 275368000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 71287000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 2638000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1367439000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 20870000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 8405000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 29275000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 71287000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 59898000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 8624252000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 0.00
POLYMED.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 2638000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Net Debt: 1579139000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -14409000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Net Income: 2582597000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 2582597000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 2582597000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 2582597000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 2582597000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 3442691000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 2582597000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Net Interest Income: -2734000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 204420000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 211196000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 211196000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -2734000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Net PPE: 9209886000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -2750996000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 14164779000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 30004000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 233000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 244834000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 62645000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 67213000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 3985041000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Normalized Income: 2430026861.30
POLYMED.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 2660822000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Operating Income: 3026545000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Operating Revenue: 13656937000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 95971417.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 178484000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 3455000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 34001000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 249945000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 141987000.00
POLYMED.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -60392000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -1000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 342000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 33226000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 922598000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Payable: 349801000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Properties: 37110000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 138767000.00
POLYMED.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 2739337000.00
POLYMED.NS income_statement (annual, 2024-03-31) — Other Special Charges: -6228000.00